EGETIS THERAPEUTICS AB NPV

The current price of 0ABW is 5.94 SEK — it has decreased by 6.75% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange EGETIS THERAPEUTICS AB NPV stocks are traded under the ticker 0ABW.

EGETIS THERAPEUTICS AB NPV is going to release the next earnings report on May 3, 2024. Keep track of upcoming events with our Earnings Calendar.

0ABW stock is 7.24% volatile and has beta coefficient of 0.92. Check out the list of the most volatile stocks — is EGETIS THERAPEUTICS AB NPV there?

0ABW earnings for the last quarter are −0.35 SEK per share, whereas the estimation was −0.26 SEK resulting in a −32.08% surprise. The estimated earnings for the next quarter are −0.35 SEK per share. See more details about EGETIS THERAPEUTICS AB NPV earnings.

EGETIS THERAPEUTICS AB NPV revenue for the last quarter amounts to ‪12.20 M‬ SEK despite the estimated figure of ‪5.25 M‬ SEK. In the next quarter revenue is expected to reach ‪8.35 M‬ SEK.

Yes, you can track EGETIS THERAPEUTICS AB NPV financials in yearly and quarterly reports right on TradingView.

0ABW stock has fallen by 1.66% compared to the previous week, the month change is a 11.21% fall, over the last year EGETIS THERAPEUTICS AB NPV has showed a 30.11% decrease.

Today EGETIS THERAPEUTICS AB NPV has the market capitalization of ‪1.68 B‬, it has increased by 4.86% over the last week.

No, 0ABW doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 0ABW shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EGETIS THERAPEUTICS AB NPV stock right from TradingView charts — choose your broker and connect to your account.

0ABW reached its all-time high on Apr 28, 2023 with the price of 9.18 SEK, and its all-time low was 3.86 SEK and was reached on Jul 21, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 27, 2024, the company has 29.00 employees. See our rating of the largest employees — is EGETIS THERAPEUTICS AB NPV on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EGETIS THERAPEUTICS AB NPV technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EGETIS THERAPEUTICS AB NPV stock shows the buy signal. See more of EGETIS THERAPEUTICS AB NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on EGETIS THERAPEUTICS AB NPV future price: according to them, 0ABW price has a max estimate of 17.70 SEK and a min estimate of 12.00 SEK. Read a more detailed EGETIS THERAPEUTICS AB NPV forecast: see what analysts think of EGETIS THERAPEUTICS AB NPV and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EGETIS THERAPEUTICS AB NPV EBITDA is ‪−316.70 M‬ SEK, and current EBITDA margin is −549.83%. See more stats in EGETIS THERAPEUTICS AB NPV financial statements.